期刊文献+

肝特异性假病毒转运系统的构建 被引量:2

Development of a liver-specific gene delivery system
原文传递
导出
摘要 目的:探索一种针对慢性乙型肝炎的特异性长效基因治疗手段。方法:改造乙型肝炎病毒(hepatitis Bvirus,HBV)为基因治疗载体,敲除其所有的开放阅读框(open reading frames,ORFs),同时保留包装信号序列,并且插入增强绿色荧光蛋白(enhanced green fluorescent protein,EGFP)作为报告基因。同时构建辅助细胞系,为上述病毒载体(假病毒)提供包装所需要的病毒蛋白。以该假病毒载体转染辅助细胞系,以酶联免疫方法检测细胞培养上清中乙型肝炎病毒抗原,并在荧光显微镜下观察EGFP的表达,用透射电镜观察培养上清中的病毒颗粒,同时用实时定量PCR的方法对分泌到细胞培养上清中的假病毒进行了定量检测。结果与结论:以假病毒载体转染辅助细胞后,电镜观察到培养上清中乙肝病毒的丹氏粒(Dane particle)。实时定量PCR分析结果显示,细胞分泌到培养上清的假病毒含量达103拷贝/μl。ELISA结果显示该上清中同时表达了HBV表面抗原和e抗原,通过荧光显微镜观察发现外源基因绿色荧光蛋白获得有效表达。 Objective:To develop a liver-specific gene delivery system for one-shot gene therapy of chronic hepatitis B virus infection. Methods: A genetically modified hepatitis B virus (the pseudovirus vector) was used as a liver-specific gene delivery viral vector. The pseudovirus vector was constructed by sequentially knocking out the viral genes ( X, C, P, and S) using PCR-based site-directed mutagenesis, and an enhanced green fluorescent protein gene (EGFP) was inserted into this pseudovirus as a reporter. Meanwhile host cell lines (helpers) expressing all the wide type HBV proteins were developed for the production of the pseudovirus. After the helpers were transfected with the pseudovirus vector, the conditioned media were analyzed for the expression of HBsAg and HBeAg by ELISA, and the pseudovirons by transmission electron microscopy and real-time PCR. The expression of EGFP was also examined by fluorescence microscopy. Results and Conclusion:After transfection with the pseudovirus, helper cells secreted the HBV pseudovirons (confirmed by real-time PCR and transmission electron microscopy), HBsAg and HBeAg (by ELISA ). The heterogeneous EGFP was expressed in the transfected helper cells.
出处 《军事医学科学院院刊》 CSCD 北大核心 2007年第4期338-342,共5页 Bulletin of the Academy of Military Medical Sciences
关键词 肝特异性 病毒载体 乙型肝炎病毒 基因转运 liver specificity viral vector hepatitis B virus gene delivery
  • 相关文献

参考文献10

  • 1Horwich AL,Furtak K,Pugh J,et al.Synthesis of hepadnavirus particles that contain replication-defective duck hepatitis B virus genomes in cultured HuH7 cells[J].J Virol,1990,64(2):642-650.
  • 2Ganem D.An advance in liver-specific gene delivery[J].Proc Natl Acad Sci USA,1999,96(21):11696-11697.
  • 3Untergasser A,Protzer U.Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters[J].Hum Gene Ther,2004,15(2):203-210.
  • 4Levine BL,Humeau LM,Boyer J,et al.Gene transfer in humans using a conditionally replicating lentiviral vector[J].Proc Natl Acad Sci USA,2006,103(46):17372-17377.
  • 5Sells MA,Chen ML,Acs G.Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA[J].Proc Natl Acad Sci USA,1987,84(4):1005-1009.
  • 6李晓萸,耿丽卿,刘敏霞,苑锡同,黄如统,李德荣.抗-HEV单克隆抗体用于四种HEV株的免疫电镜研究[J].细胞与分子免疫学杂志,1998,14(4):272-274. 被引量:1
  • 7Lupberger J,Mund A,Kock J,et al.Cultivation of HepG2.2.15 on Cytodex-3:higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods[J].J Hepatol,2006,45(4):547-552.
  • 8Ganem D,Prince AM.Hepatitis B virus infection-natural history and clinical consequences[J].N Engl J Med,2004,350(11):1118-1129.
  • 9Zhu Y,Cullen JM,Aldrich CE,et al.Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus[J].Virology,2004,327(1):26-40.
  • 10Berraondo P,Ochua L,Crettaz J,et al.IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus:differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes[J].Mol Ther,2005,12(1):68-76.

二级参考文献6

同被引文献19

  • 1梁蔚芳,刘志华,杨洁,骆抗先.Ad-1.2乙型肝炎病毒感染HepG2细胞后HBV cccDNA的动态分析[J].南方医科大学学报,2007,27(9):1374-1375. 被引量:8
  • 2Isaacs A,Lindenmann J.Virus interference.Ⅰ.The interferon[J].Proc R Soc Lond B Biol Sci,1957,147(927):258-267.
  • 3Liu C,Zhu H,Subramanian GM,Moore PA,Xu Y,Nelson DR.Anti-hepatitis C virus activity of albinterferon alfa-2b in cell culture[J].Hepatol Res,2007,37(11):941-947.
  • 4Chuang VT,Kragh-Hansen U,Otagiri M.Pharmaceutical strategies utilizing recombinant human serum albumin[J].Pharm Res,2002,19(5):569-577.
  • 5Osborn BL,Olsen HS,Nardelli B,Murray JH,Zhou JX,Garcia A,et al.Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys[J].J Pharmacol Exp Ther,2002,303(2):540-548.
  • 6Ren S,Nassal M.Hepatitis B virus(HBV)virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors[J].J Virol,2001,75(3):1104-1116.
  • 7Tur-Kaspa R,Teicher L,Laub O,Itin A,Dagan D,Bloom BR,et al.Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription[J].J Virol,1990,64(4):1821-1824.
  • 8Zhang X,Zhang E,Ma Z,Pei R,Jiang M,Schlaak JF,et al.Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1[J].Hepatology,2011,53(5):1476-1485.
  • 9Belloni L,Allweiss L,Guerrieri F,Pediconi N,Volz T,Pollicino T,et al.IFN-αinhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome[J].J Clin Invest,2012,122(2):529-537.
  • 10曹颖莉,郭颖.应用假病毒技术研究HIV-1复制抑制剂[J].药学学报,2008,43(3):253-258. 被引量:23

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部